Atlas Trials

A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers

Clinical trial NCT05928585 · COMPLETED

Trial details

NCT number
NCT05928585
Sponsor
HI-Bio, A Biogen Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Immune System DiseasesAutoimmunity
Start date
2023-07-06
Primary completion
2024-06-10
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.